Gerald H. Friedland, MD
(Article PDF) CROI 2018: Epidemic Trends and Advances in HIV Prevention
At the 2018 Conference on Retroviruses and Opportunistic Infections, trends in and risk factors for in HIV infection were highlighted. In the United States, new HIV diagnoses are highest in the South and among African Americans and are increasing in rural areas. Youth remain highly vulnerable to HIV infection globally. The epidemiology of HIV infections among people who inject drugs is changing, with overdose deaths, a major public health concern. Phylogenetics are being used to identify HIV transmission clusters and hotspots, which can inform prevention efforts. Vaginal microbial dysbiosis and proteomic alterations are associated with increased risk of HIV acquisition, as are the pregnancy and postpartum periods. HIV testing is a central first step for the HIV care and treatment continua, and several innovative strategies to expand HIV testing coverage and frequency show promise. Preexposure prophylaxis (PrEP) uptake is rapidly increasing in some cities, with reductions of new infections at the population level, but use is lower among African Americans and Latinos, youth, cis- and transgender women, and people who inject drugs. PrEP continuation remains a challenge. Two open-label extension studies of the dapivirine vaginal ring demonstrated high uptake, adherence, and reduced HIV infections. Several novel systemic and topical prevention agents show promise in non-human primates.
Ronald T. Mitsuyasu, MD
Latest Update on Urgent Virus Outbreaks: June 2024 Dialogue Now Open For Registration
2023 The IAS–USA Annual Update on HIV Management in Chicago, Illinois
New and Investigational Antiretroviral Drugs and Formulations Presenter: Constance A. Benson, MD In Case You Missed It: CROI 2023, Publications, and Guidelines Presenter: Roger J. Bedimo, MD, MS Challenging Cases in Antiretroviral Therapy and Panel Discussion Presenter: Michael S. Saag, MD The Latest Updates on HIV Prevention Presenter: Raphael J. Landovitz, MD, MSc Treatment and […]
New Article Available from Topics in Antiviral Medicine™
An early e-publication article summarizing key data on new research in preexposure prophylaxis for people with HIV is now available from the peer-reviewed IAS-USA journal Topics in Antiviral Medicine™. This article was based in part from data presented by Dr Raphael J. Landovitz during the Unique Issues in HIV Prevention, Treatment, and Care in the […]
Reminder to Sign Up For July 27th Webinar on the Microbiome and Impact on Disease in HIV and COVID-19
Nichole Klatt, PhD (University of Minnesota) will be presenting a webinar on The Role of the Microbiome in Modulation of Inflammation and Impact on Disease in HIV and COVID-19, scheduled July 27th webinar. For more information, visit https://www.iasusa.org/events/webinar-2021-klatt/.
Data Presented at vCROI 2021 Included in March 16th Webinar on SARS-CoV-2 Variants
Dr Jonathan Li, MD, MMsc, from Harvard Medical School, will be including data presented at virtual CROI 2021 for our upcoming webinar on Fighting a Moving Target: SARS-CoV-2 Variants and Viral Escape. Note, registration closes on Monday, March 15, 2021, 4:00 PM (PT).
Live Dialogue Happening Now: Continued Discussion on COVID-19 Epidemiology and Transmission
Please use the following Sign In link to access the live Dialogue happening now, from 3:00 PM – 4:00 PM PT (4:00 PM – 5:00 PM MT; 5:00 PM – 6:00 PM CT; 6:00 PM – 7:00 PM ET): https://zoom.us/webinar/register/WN_r83yyfmYQ_-YMFcyFGTfVg